Follow us:

News & events

  • Home
  • News & informations
  • Commercializing Continuous Processing in Pharma 2017

Commercializing Continuous Processing in Pharma 2017

Boston, 30th January 2017 - 1st February 2017

  • by Ypso-Facto
  • January 25, 2017
Commercializing Continuous Processing in Pharma 2017

Margit Holzer and David Pfister present a workshop on End-to-End Continuous Manufacturing: Is This Possible?  and Margit Holzer chairs a roundtable discussion: How to Develop the Control Strategy for Continuous Processing?

 

Worshop overview:

This workshop is the guidebook for E2E CM approach and implementation.

Attend this workshop to:

  • Learn the definitions, processes and technologies in the context of continuous bio-manufacturing
  • Set the objectives and goals for continuously run unit operations and whole process lines
  • Evaluate examples of how to develop and what to consider during implementation

 

Roundtable synopsis:

  • Comparing the similarities and differences between production processes of small molecules and biologics
  • How to define the control strategy for continuous processing?
  • Which parameters need to be considered? How to scale up?
  • Risk mitigation plan – what is best practice and what are the regulatory concerns?

Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.

Learn more

Contact Us
© Ypso-Facto 2014 - Powered by Ealys | Legal Information